Loading clinical trials...
Loading clinical trials...
Past studies have shown that MRI is useful for staging prostate cancer. This study will use magnetic resonance spectroscopic imaging (MRSI) to obtain more information. MRSIs with MRIs help doctors locate prostate cancer and determine the extent of tumor before deciding on treatment. This study looks at structural and chemical properties of prostates in prostate cancer patients before and after treatment.
Age
18 - No limit years
Sex
MALE
Healthy Volunteers
No
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Start Date
December 1, 2000
Primary Completion Date
February 1, 2013
Completion Date
February 1, 2013
Last Updated
October 24, 2023
1,005
ACTUAL participants
MRI and MRSI
OTHER
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
NCT06842498
NCT05691465
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04550494